0001517941-18-000003.txt : 20180713 0001517941-18-000003.hdr.sgml : 20180713 20180713155719 ACCESSION NUMBER: 0001517941-18-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180713 DATE AS OF CHANGE: 20180713 EFFECTIVENESS DATE: 20180713 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Carmell Therapeutics Corp CENTRAL INDEX KEY: 0001517941 IRS NUMBER: 263671988 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-316859 FILM NUMBER: 18952530 BUSINESS ADDRESS: STREET 1: 10 SOUTH TOWER STREET 2: 320 E. NORTH AVENUE CITY: PITTSBURGH STATE: PA ZIP: 15212 BUSINESS PHONE: (412) 508-6519 MAIL ADDRESS: STREET 1: 10 SOUTH TOWER STREET 2: 320 E. NORTH AVENUE CITY: PITTSBURGH STATE: PA ZIP: 15212 D 1 primary_doc.xml X0708 D LIVE 0001517941 Carmell Therapeutics Corp 2403 Sidney Street Suite 300 PITTSBURGH PA PENNSYLVANIA 15203 215-688-6196 DELAWARE CarMell, LLC None Corporation true Randolph Hubbell c/o Carmell Therapeutics Corporation 2403 Sidney Street, Suite 300 Pittsburgh PA PENNSYLVANIA 15203 Executive Officer Director James Hart c/o Carmell Therapeutics Corporation 2403 Sidney Street, Suite 300 Pittsburgh PA PENNSYLVANIA 15203 Executive Officer Donna Godward c/o Carmell Therapeutics Corporation 2403 Sidney Street, Suite 300 Pittsburgh PA PENNSYLVANIA 15203 Executive Officer Richard Upton c/o Carmell Therapeutics Corporation 2403 Sidney Street, Suite 300 Pittsburgh PA PENNSYLVANIA 15203 Director James F. Jordan c/o Carmell Therapeutics Corporation 2403 Sidney Street, Suite 300 Pittsburgh PA PENNSYLVANIA 15203 Director David W. Anderson c/o Carmell Therapeutics Corporation 2403 Sidney Street, Suite 300 Pittsburgh PA PENNSYLVANIA 15203 Director Stephanie Kladakis c/o Carmell Therapeutics Corporation 2403 Sidney Street, Suite 300 Pittsburgh PA PENNSYLVANIA 15203 Executive Officer Biotechnology Decline to Disclose 06b false 2018-07-09 false true true false 0 Dalmore Group, LLC 136352 None None 525 Green Place Woodmere NY NEW YORK 11598 RI RHODE ISLAND VT VERMONT ME MAINE VA VIRGINIA MI MICHIGAN DE DELAWARE ID IDAHO IA IOWA MD MARYLAND MA MASSACHUSETTS AR ARKANSAS IL ILLINOIS UT UTAH IN INDIANA MN MINNESOTA AZ ARIZONA MO MISSOURI MT MONTANA MS MISSISSIPPI NH NEW HAMPSHIRE NJ NEW JERSEY NM NEW MEXICO AK ALASKA AL ALABAMA TX TEXAS NC NORTH CAROLINA ND NORTH DAKOTA NE NEBRASKA NY NEW YORK GA GEORGIA NV NEVADA TN TENNESSEE CA CALIFORNIA OK OKLAHOMA OH OHIO WY WYOMING FL FLORIDA SD SOUTH DAKOTA SC SOUTH CAROLINA CT CONNECTICUT WV WEST VIRGINIA DC DISTRICT OF COLUMBIA KY KENTUCKY WI WISCONSIN KS KANSAS OR OREGON LA LOUISIANA WA WASHINGTON CO COLORADO PA PENNSYLVANIA false 4500000 1150000 3350000 $400,000 of total $1,150,000 represents convertible promissory notes issued in exchange for equity. false 8 405000 true 0 Represents up to 9% placement agent fee. 0 false Carmell Therapeutics Corp Randolph W. Hubbell Randolph W. Hubbell Chief Executive Officer and President 2018-07-13